Altamira Therapeutics Partners with Undisclosed Company to Advance Circular RNA Delivery Platform
Altamira Therapeutics has entered into a collaboration agreement with an undisclosed company to evaluate its CycloPhore platform for delivering circular RNA payloads.
Altamira Therapeutics Partners with Radiopharmaceutical Company to Enhance Cancer Treatment Targeting
Altamira Therapeutics has entered into a collaboration agreement with an undisclosed radiopharmaceutical company to evaluate the use of its proprietary RNA delivery platform for enhanced cancer targeting.